Overview
  • Transaction Name: Swiftmerge Acquisition Corp. / HDL Therapeutics, Inc.
  • Acquirer: Swiftmerge Acquisition Corp.
  • Target: HDL Therapeutics, Inc.
  • Announcement Date: August 11, 2023
  • Status: Pending
Loading...
  • of